ARC Bio, LLC
Cambridge, MA · Medtech · Private
Galileo ONE – CSF, a sample-to-answer metagenomic next-generation sequencing platform for rapid pathogen detection from cerebrospinal fluid samples
- Grants
- $6.3M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 11 granted · 29 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a kit for the targeted depletion of abundant sequencesfrom DNA/RNA libraries | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a kit for the targeted depletion of abundant sequencesfromDNA/RNA libraries | $1,997,842 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a sample-to-answer sequencing pipeline for detection of viral infections and co-infections in immunocompromised transplant patients. | $247,853 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a kit for the targeted depletion of abundant sequencesfromDNA/RNA libraries | $998,921 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and validation of a sample-to-answer metagenomics workflow for comprehensive pathogen detection in central nervous system infections | $1,928,809 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and validation of a sample-to-answer metagenomics workflow for comprehensive pathogen detection in central nervous system infections | $931,074 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1173 | Epica International, Inc. | — | $19M |
| 1174 | Houston Medical Robotics, Inc. | — | $87K |
| 1175 | Swift Medical Inc. | — | $23M |
| 1176 | ARC Bio, LLC | — | — |
| 1177 | MARVEL MEDTECH, LLC | — | — |
| 1178 | EvoEndo, Inc. | — | $4.7M |
| 1179 | ANALYTICAL DIAGNOSTIC SOLUTIONS INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Ligation Free Methods Of Nucleic Acid Library Preparationapplication
- Machine Learning Techniques For Analysis Of Structural Variantsapplication
- Systems, Methods, And Media For Classifying Genetic Sequencing Resultsapplication
- Compositions And Methods For Making Guide Nucleic Acidsapplication
- Differential Methylation Enrichment Methods And Uses Thereofapplication
- Pre-library Depletion Of Nucleic Acidsapplication
- Systems And Methods For Genomic Analysisapplication
- Non-ribosomal Sequence Enrichment And Single-stranded Dna Library For Nucleic Acid Guided Nuclease Targetingapplication
- Systems And Methods For Genomic Analysisgranted
- Systems And Methods For Genomic Manipulations And Analysisgranted
- Ligation Free Methods Of Nucleic Acid Library Preparationapplication
- Systems, Methods, And Media For Classifying Genetic Sequencing Results Based On Pathogen-specific Adaptive Thresholdsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.